Cambridge Healthtech Institute's Inaugural
Digital Therapeutics
Data-Driven Treatment Options
May 14-15, 2019
With technology at the forefront of our everyday lives, data-driven treatment options are now taking center stage in patient health. This has led to the rapid rise of digital therapeutics. CHI’s Digital Therapeutics conference gathers leaders across
pharma, biotech, healthcare and academia for discussions and case studies on leveraging new technologies to enhance patient health. Special focus will be given to the challenges, solutions, and opportunities that lie in the validation, adoption, and
use of digital therapeutics.
Final Agenda
Day 1 | Day 2 | Download Brochure
Tuesday, May 14
10:00 am Conference Registration
10:45 PLENARY KEYNOTE SESSION: Enabling Patient-Centric Clinical Trials
10:45 Chairperson Remarks: Patient-Centric Trials: How to Engage the Patients in a Clinical Study
Basker Gummadi, IT Strategy & Digital Transformation, Digital Innovation, Bayer U.S. LLC
Basker will share the results of the patients’ interaction and what is important to them and what keeps them engaged in a trial. He will also share his personal vision of how Digital technologies can help in this space.
10:55 KEYNOTE PRESENTATION: Patient-Centric Trials: Moving from What’s the Matter with Patients to What Matters to Patients
.png)
Lisa Shipley, Vice President, Global Digital Analytics, Merck
The overall percentage of potential patients that participate in clinical trial is very low. Engaging patients and removing barriers to patient participation in clinical trials is critically important to the development of new therapies to improve human
health. Digital technologies are poised to improve patient participation and experience and shift from a site-centric to a patient-centric model. Pharmaceutical companies and CRO’s are exploring a number of different paradigms deploying technologies
such as, telemedicine, wearables, and home-sampling.
11:15 KEYNOTE PANEL DISCUSSION: Going Virtual – Moving towards Patient-Centric, Site-Less Trials
Lisa Shipley, Vice President, Global Digital Analytics, Merck
Linnea Olson, Lung Cancer Patient Advocate
Laura Whitmore, Director, R&D Innovation, Corporate Projects, Otsuka
Basker Gummadi, IT Strategy & Digital Transformation, Digital Innovation, Bayer U.S. LLC
With the rise and integration of new technologies into clinical trials – mHealth, wearables, sensors, the internet of things – there is an unprecedented opportunity for revolutionizing how the industry performs clinical trials. New technology
can help move clinical trials from sites directly into patient homes.
- Virtual trials, decentralized trials, remote trials, site-less trials: What are we all talking about?
- What are the latest successes and failures?
- What are the barriers and challenges? How is the industry leveraging technology to make this a reality?
- What are patients saying about their experience with virtual trials?
- What does this mean for the future of clinical trials?
11:50 Keynote Luncheon Presentation (Sponsorship Opportunity Available) or Lunch on Your Own
12:35 pm Dessert Break in the Exhibit Hall
1:45 Chairperson’s Remarks
1:50 Prescription of Digital Therapeutics: The Time Has Arrived!
Ashish Atreja, MD, MPH, FACP, Chief Technology Innovation and Engagement Officer, Medicine, Icahn School of Medicine at Mount Sinai
2:20 Digital Health: Sharing Lessons Learned
Georgia Mitsi, Senior Director, Head of Digital Healthcare Initiatives, Sunovion Pharmaceuticals
2:50 Sponsored Presentation (Opportunity Available)
3:20 Refreshment Break in the Exhibit Hall
4:05 Talk Title to be Announced
Brian Johnson, Associate Director, Corporate Projects, R&D Innovation, Otsuka
4:35 Presentation to be Announced
5:05 Session Break
5:30 Start-Up Showcase and Networking Reception
As a part of the Clinical Trial Innovation Summit, attendees are welcome to attend Tuesday night’s Start-Up Showcase and Networking Reception. As technological advances rapidly enter the market, it may become a challenge to keep up and ensure that
your organization is effectively leveraging these technologies for improved clinical trial efficiency. Come listen to and network with new, emerging companies in the digital tech space as they provide brief descriptions of their companies and their
services or products. Over cocktails in our open reception, connect with emerging products and service providers in the clinical trial space with special focus on the wearable and digital tech space.
7:30 Close of Day
Day 1 | Day 2 | Download Brochure
Wednesday, May 15
8:30 am Interactive Breakout Discussion Groups with Continental Breakfast
Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become
an active part of the discussion at hand. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and most
importantly, participate in active idea sharing.
9:25 Session Break
9:40 Chairperson’s Remarks
9:45 Managing Chronic Disease Progression with Digital Therapeutics
Speaker to be Announced
10:15 Digitizing the Development Process: How Digital Therapeutics Open the Door to Innovation
Randall Kaye, CMO, Click Therapeutics
This presentation will 1. Look at the progress being made in clinically validated digital therapeutics, including the Click Therapeutics pipeline and emerging partnerships with pharma, 2. Discuss lessons learned from Click’s digital study: How enrollment,
eligibility, and consent processes were improved through digitization, and 3. Evaluate opportunities for future innovation in digital studies.
10:45 Sponsored Presentation (Opportunity Available)
11:00 Coffee Break
11:30 Presentation to be Announced
12:00 pm Presentation to be Announced
12:30 Luncheon Presentation (Sponsorship Opportunity Available) or Lunch on Your Own
1:15 Session Break
2:15 Chairperson’s Remarks
2:20 Presentation to be Announced
2:50 PANEL DISCUSSION: Future of Digital Therapeutics – Where Do Opportunities Lie?
Speaker to be Announced
Although digital therapeutics are poised to dramatically change patient treatment options and disease management, the field is still relatively new. As a new discipline, there remains many challenges and opportunities as the industry delves into clinically-validated
digital interventions. Topics discussed in this panel include:
- FDA and regulatory approval
- Partnerships in digital therapeutics
- Therapeutic areas ripe for digital therapeutics
3:50 Close of Conference. Arrive early to attend Big Data Analytics, Machine Learning and Artificial Intelligence for Clinical Trials.
Day 1 | Day 2 | Download Brochure